Crisis Management

A Veneer of Health

The Burson-Marsteller PR firm did pro bono communications and media relations support for America's Health Care at Risk: Finding a Cure, which is billed as "a bi-partisan conference bringing together major stakeholders in the health care debate for a high-level dialogue aimed at generating real and lasting solutions." While organizers of the conference were thrilled to have the free help, they may have been wise to check on B-M's health credentials.


Depends Who You Work For: Half Empty or Half Full?

Starbucks logoWhile the closing of 600 Starbucks stores is bad news for the 12,000 baristas who will lose their jobs, it's an economic plus for others. The coffee giant is ramping up PR efforts to shape its message about its contraction.


Spinning the Spin on Barack Obama

Obama New YorkerThe cover of the upcoming issue of the New Yorker magazine bears a satirical cartoon that incorporates practically every jab the right wing has taken at Barack Obama and his wife Michelle: the couple is pictured standing


Jeff Gannon, National Press Club member

Jeff Gannon"If you ever wondered what happened to Jeff Gannon, the former conservative reporter whose questionable White House credentialing and ties to several sex Web sites forced him out of a job," he's an active member of the National Press Club.


"Bad Apple" Theory Rotting

Dick CheneyThe Bush administration has long held that overly-aggressive interrogation methods used on detainees in Abu Ghraib and Guantanamo Bay were the work of a few "bad apples." Now, an investigation being conducted


Damage Control All Over Again

For Richard A. Clarke, the former Bush administration security advisor whose tell-all book was denounced as a betrayal four years ago, the current White House attacks on former press secretary Scott McClellan are reminiscent of what he went through. "It's like an echo chamber," he told Comedy Central's The Daily Show.


Thanks to Chantix, Quitting Smoking May Be Hazardous, Too

antismoking drug ChantixThe pharmaceutical company Pfizer "is preparing an advertising and public-relations campaign to counter concerns about its antismoking drug Chantix, once trumpeted as a potential billion-dollar-a-year blockbuster." So far, Pfizer has "run ads in five major newspapers in which its medical director explains Chantix's risk-benefit balance." The drug company will soon "start hosting ro



Subscribe to Crisis Management